Published 2003
| Version v1.0.0
Journal Article
Open
OROS Methylphenidate Long-Term Study in ADHD
Creators
Abstract
Once-daily osmotic controlled-release (OROS) methylphenidate (Concerta) in the treatment of 407 children, aged 6-13 years, with ADHD who were known MPH responders, was evaluated in a 24-month multicenter, open-label, nonrandomized study, and reported from the Massachusetts General Hospital, Boston.Files
PNB-17-40-b.pdf
Files
(1.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:10f01a012dfd4e0b80361a1f39f6e30f
|
1.3 MB | Preview Download |
Additional details
Identifiers
- Other
- PNB-17-40-b
Dates
- Created
-
2003When the item was originally created.